The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Cannabinoid-induced apoptosis in immune cells as a pathway to immunosuppression
Open accessAbstract
Cannabinoids are a group of compounds present in Cannabis plant (Cannabis sativa L.). They mediate their physiological and behavioral effects by activating specific cannabinoid receptors. With the recent discovery of the cannabinoid receptors (CB1 and CB2) and the endocannabinoid system, research in this field has expanded exponentially. Cannabinoids have been shown to act as potent immunosuppressive and anti-inflammatory agents and have been shown to mediate beneficial effects in a wide range of immune-mediated diseases such as multiple sclerosis, diabetes, septic shock, rheumatoid arthritis, and allergic asthma. Cannabinoid receptor 1 (CB1) is mainly expressed on the cells of the central nervous system as well as in the periphery. In contrast, cannabinoid receptor 2 (CB2) is predominantly expressed on immune cells. The precise mechanisms through which cannabinoids mediate immunosuppression is only now beginning to be understood and can be broadly categorized into four pathways: apoptosis, inhibition of proliferation, suppression of cytokine and chemokine production and induction of T regulatory cells (T regs). Studies from our laboratory have focused on mechanisms of apoptosis induction by natural and synthetic cannabinoids through activation of CB2 receptors. In this review, we will focus on apoptotic mechanisms of immunosuppression mediated by cannabinoids on different immune cell populations and discuss how activation of CB2 provides a novel therapeutic modality against inflammatory and autoimmune diseases as well as malignancies of the immune system, without exerting the untoward psychotropic effects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hengartner, M. O. (2000) · Nature · doi:10.1038/35037710 · Cited by 5,779
Mitochondrial control of cell death
Kroemer, G., & Reed, J. C. (2000) · Nature Medicine · doi:10.1038/74994 · Cited by 3,103
Death and anti-death: tumour resistance to apoptosis
Igney, F. H., & Krammer, P. H. (2002) · Nature Reviews Cancer · doi:10.1038/nrc776 · Cited by 2,075
Cannabidiol and (−)Δ 9 -tetrahydrocannabinol are neuroprotective antioxidants
Hampson, A. J., Grimaldi, M., Axelrod, J., & Wink, D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.14.8268 · Cited by 850 · cited 2×
“There are few reports also showing receptor-independent actions of cannabinoids, such as in B cells and rat cortical neurons (Hampson et al. 1998; Chen and Buck 2000).”
BackgroundCannabinoids: potential anticancer agents
Guzmán, M. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1188 · Cited by 703
Cannabinoids for control of chemotherapy induced nausea and vomiting: quantitative systematic review
Tramèr, M. R., Carroll, D., Campbell, F. A., Reynolds, D. J. M., Moore, R. A., & McQuay, H. J. (2001) · BMJ · doi:10.1136/bmj.323.7303.16 · Cited by 610 · cited 3×
“Cannabinoids have been approved in some countries for the treatment of chemotherapy-induced nausea and vomiting, and clinical trials show cannabinoids’ effectiveness in pain inhibition and appetite stimulation (Guzman 2003; Tramer et al. 2001).”
BackgroundCancer Anorexia-Cachexia Syndrome: Current Issues in Research and Management
Inui, A. (2002) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.52.2.72 · Cited by 579
CANNABINOID RECEPTORS AS THERAPEUTIC TARGETS
Mackie, K. (2006) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.46.120604.141254 · Cited by 505
Varga, K., Wagner, J. A., Bridgen, D. T., & Kunos, G. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.11.1035 · Cited by 410
Anandamide Induces Apoptosis in Human Cells via Vanilloid Receptors
Maccarrone, M., Lorenzon, T., Bari, M., Melino, G., & Finazzi-Agrò, A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005722200 · Cited by 347
Karst, M., Salim, K., Burstein, S., Conrad, I., Hoy, L., & Schneider, U. (2003) · JAMA · doi:10.1001/jama.290.13.1757 · Cited by 340
Cannabinoid receptors as novel targets for the treatment of melanoma
Blázquez, C., Carracedo, A., Barrado, L., José Real, P., Luis Fernández‐Luna, J., Velasco, G., Malumbres, M., Guzmán, M., Blázquez, C., Carracedo, A., et al. (2006) · The FASEB Journal · doi:10.1096/fj.06-6638fje · Cited by 292
Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease
McKallip, R. J., Lombard, C., Fisher, M., Martin, B. R., Ryu, S., Grant, S., Nagarkatti, P. S., & Nagarkatti, M. (2002) · Blood · doi:10.1182/blood-2002-01-0098 · Cited by 288
Self-citationCannabinoids and the immune system: Potential for the treatment of inflammatory diseases?
Croxford, J. L., & Yamamura, T. (2005) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2005.04.023 · Cited by 255
McKallip, R. J., Nagarkatti, M., & Nagarkatti, P. S. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.6.3281 · Cited by 245
Self-citationCannabinoid receptors and immunity
Klein, T. W., Newton, C., & Friedman, H. (1998) · Immunology Today · doi:10.1016/s0167-5699(98)01300-0 · Cited by 234
The Cannabinoid System and Cytokine Network
Klein, T. W., Lane, B., Newton, C. A., & Friedman, H. (2000) · Proceedings of the Society for Experimental Biology and Medicine · doi:10.1046/j.1525-1373.2000.22501.x · Cited by 214
McKallip, R. J., Jia, W., Schlomer, J., Warren, J. W., Nagarkatti, P. S., & Nagarkatti, M. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.023937 · Cited by 211
Self-citationDo, Y., McKallip, R. J., Nagarkatti, M., & Nagarkatti, P. S. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.4.2373 · Cited by 195
Self-citationSchwarz, H., Blanco, F. J., & Lotz, M. (1994) · Journal of Neuroimmunology · doi:10.1016/0165-5728(94)90152-x · Cited by 180
Respiratory and Immunologic Consequences of Marijuana Smoking
Tashkin, D. P., Baldwin, G. C., Sarafian, T., Dubinett, S., & Roth, M. D. (2002) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.2002.tb06006.x · Cited by 178
Cannabinoid-Induced Immune Suppression and Modulation of Antigen-Presenting Cells
Klein, T. W., & Cabral, G. A. (2006) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-005-9007-x · Cited by 172
Cannabinoids enhance human B‐cell growth at low nanomolar concentrations
Derocq, J.-M., Ségui, M., Marchand, J., Le Fur, G., & Casellas, P. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)00746-v · Cited by 167
Rajesh, M., Pan, H., Mukhopadhyay, P., Bátkai, S., Osei‐Hyiaman, D., Haskó, G., Liaudet, L., Gao, B., & Pacher, P. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0307180 · Cited by 165
Guzmán, M., Sánchez, C., & Galve-Roperh, I. (2002) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00256-5 · Cited by 161
Hegde, V. L., Hegde, S., Cravatt, B. F., Hofseth, L. J., Nagarkatti, M., & Nagarkatti, P. S. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.047035 · Cited by 154
Self-citationEvidence for the Induction of Apoptosis in Thymocytes by 2,3,7,8-Tetrachlorodibenzo-p-dioxinin Vivo
Kamath, A. B., Xu, H., Nagarkatti, P. S., & Nagarkatti, M. (1997) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1996.8049 · Cited by 148
Self-citationCurrent Management of Pain Associated with Multiple Sclerosis
Pöllmann, W., & Feneberg, W. W. (2008) · CNS Drugs · doi:10.2165/00023210-200822040-00003 · Cited by 147
McKallip, R. J., Lombard, C., Martin, B. R., Nagarkatti, M., & Nagarkatti, P. S. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.033506 · Cited by 143
Self-citationZhu, W., Friedman, H. P., & Klein, T. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37693-1 · Cited by 137
Lombard, C. A., Nagarkatti, M., & Nagarkatti, P. S. (2006) · Clinical Immunology · doi:10.1016/j.clim.2006.11.002 · Cited by 136
Self-citationCondie, R. B., Herring, A. C., Koh, W. S., Lee, M., & Kaminski, N. E. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.22.13175 · Cited by 133
Filippo, C. D., Rossi, F., Rossi, S., & D’Amico, M. (2003) · Journal of Leukocyte Biology · doi:10.1189/jlb.0703303 · Cited by 132
Wang, Y., Liu, Y., Ito, Y., Hashiguchi, T., Kitajima, I., Yamakuchi, M., Shimizu, H., Matsuo, S., Imaizumi, H., & Maruyama, I. (2001) · Analytical Biochemistry · doi:10.1006/abio.2001.5015 · Cited by 130
Cannabinoids Protect Cells from Oxidative Cell Death: A Receptor-Independent Mechanism
Chen, Y., & Buck, J. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39301-2 · Cited by 125
Zhu, W., Friedman, H. P., & Klein, T. (1998) · PubMed · Cited by 113
Jia, W., Hegde, V. L., Singh, N. P., Sisco, D., Grant, S., Nagarkatti, M., & Nagarkatti, P. S. (2006) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-05-0193 · Cited by 110
Self-citationHerrera, B. M., Carracedo, A., Diez-Zaera, M., del Pulgar, T. G., Guzmán, M., & Velasco, G. (2006) · Experimental Cell Research · doi:10.1016/j.yexcr.2006.03.009 · Cited by 104
Zurier, R. B., Rossetti, R. G., Lane, J. H., Goldberg, J. M., Hunter, S. A., & BURSTEIN, S. H. (1998) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199801)41:1<163::aid-art20>3.0.co;2-9 · Cited by 103
Lee, S. F., Newton, C. A., Widen, R. E., Friedman, H. P., & Klein, T. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01122-0 · Cited by 100
A comparative study on cannabidiol-induced apoptosis in murine thymocytes and EL-4 thymoma cells
Lee, C.-Y., Wey, S., Liao, M.-H., Hsu, W., Wu, H., & Jan, T. (2008) · International Immunopharmacology · doi:10.1016/j.intimp.2008.01.018 · Cited by 91
Tetrahydrocannabinol-Induced Suppression of Macrophage Spreading and Phagocytic Activity In Vitro
Lopez-Cepero, M. M., Friedman, M., Klein, T., & Friedman, H. P. (1986) · Journal of Leukocyte Biology · doi:10.1002/jlb.39.6.679 · Cited by 83
Lombard, C. A., Nagarkatti, M., & Nagarkatti, P. S. (2005) · Leukemia Research · doi:10.1016/j.leukres.2005.01.014 · Cited by 77
Self-citationdelta 9-Tetrahydrocannabinol modulates antigen processing by macrophages.
McCoy, K. L., Gainey, D., & Cabral, G. A. (1995) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)09609-0 · Cited by 74 · cited 1×
“Several studies have shown that cannabinoids negatively regulate phagocytosis, cell-spreading and antigen presentation by macrophages (Cabral and Mishkin 1989; LopezCepero et al. 1986; McCoy et al. 1995).”
BackgroundLu, T., Newton, C. A., Perkins, I., Friedman, H. P., & Klein, T. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.108381 · Cited by 70
El-Gohary, M., & Eid, M. A. E.-W. (2004) · Human & Experimental Toxicology · doi:10.1191/0960327104ht426oa · Cited by 65
Intact humoral and cell-mediated immunity in chronic marijuana smoking
Rachelefsky, G. S., Opelz, G., Mickey, M. R., Lessin, P. J., Kiuchi, M., Silverstein, M. J., & Stiehm, E. R. (1976) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(76)90192-5 · Cited by 63
9-Tetrahydrocannabinol, Cytokines, and Immunity to Legionella pneumophila
Klein, T., Newton, C., Zhu, W., Daaka, Y., & Friedman, H. P. (1995) · Experimental Biology and Medicine · doi:10.3181/00379727-209-43897b · Cited by 56
Singh, N. P., Nagarkatti, M., & Nagarkatti, P. S. (2008) · Molecular Pharmacology · doi:10.1124/mol.107.043406 · Cited by 48
Self-citationZhu, W., Newton, C. A., Daaka, Y., Friedman, H., & Klein, T. (1994) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22543-5 · Cited by 47
Camacho, I. A., Hassuneh, M. R., Nagarkatti, M., & Nagarkatti, P. S. (2001) · Toxicology · doi:10.1016/s0300-483x(01)00391-2 · Cited by 46
Self-citationGeorge, K. L., Saltman, L. H., Stein, G. S., Lian, J. B., & Zurier, R. B. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.21263 · Cited by 45
Cabral, G. A., & Mishkin, E. M. (1989) · Journal of Toxicology and Environmental Health · doi:10.1080/15287398909531243 · Cited by 34
Yebra, M., Klein, T., & Friedman, H. (1992) · Life Sciences · doi:10.1016/0024-3205(92)90009-e · Cited by 27
delta 9-Tetrahydrocannabinol (THC) causes the variable expression of IL2 receptor subunits.
Zhu, W., Igarashi, T., Friedman, H. P., & Klein, T. (1995) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10542-9 · Cited by 15
Cited by
Seely, K. A., Lapoint, J., Moran, J. H., & Fattore, L. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.04.017 · Cited by 465
Towards the use of cannabinoids as antitumour agents
Velasco, G., Sánchez, C., & Guzmán, M. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3247 · Cited by 372
Schizophrenia and autism: both shared and disorder-specific pathogenesis via perinatal inflammation?
MEYER, U., FELDON, J., & DAMMANN, O. (2011) · Pediatric Research · doi:10.1203/pdr.0b013e318212c196 · Cited by 357
“Consistent with this suggestion, exposure to environmental insults such as stress and drugs of abuse, which are believed to facilitate or even trigger the onset of full-blown psychosis in individuals at high risk for schizophrenia (73), are also known to exert direct influences on the immune system (74,75).”
Mecha, M., Feliú, A., Iñigo, P. M., Mestre, L., Carrillo-Salinas, F. J., & Guaza, C. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.06.016 · Cited by 285
Boileau, I., Mansouri, E., Williams, B., Le Foll, B., Rusjan, P., Mizrahi, R., Tyndale, R. F., Huestis, M. A., Payer, D. E., Wilson, A. A., et al. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.04.012 · Cited by 82
Metadata
- Authors
- Rieder, S. A., Chauhan, A., Singh, U., Nagarkatti, M., & Nagarkatti, P.
- Venue
- Immunobiology
- Publisher
- Elsevier BV
- Published
- 2010-08
- Volume
- 215
- Issue
- 8
- Pages
- 598-605
- ISSN
- 0171-2985 (ISSN-L)
- OpenAlex
- W2168065686
- Cited by
- 263
- References
- 55
- FWCI
- 8.11
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.